Immuron IMRN
NASDAQ IMRN
$1.24 +0.02 (+1.64%)
At close: Sep 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Change in Account Payables (2020 - 2021)

Immuron (IMRN) posted Change in Account Payables of $451865.3 for Q2 2021, up 290.22% on a QoQ basis from -$237548.7 in Q2 2020, and up 290.22% year-over-year from $115797.5 in Q2 2020.

Analysis

Immuron (IMRN) Change in Account Payables (2020 - 2021) Analysis & Trends

Immuron has reported Change in Account Payables for 2 years, with the latest figure at $451865.3 in Q2 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -8.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 7.11 Mn
10 Immuron 7.14 Mn -1.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 451,865.28
Jun 30, 2020 -237,548.69
API Access

Immuron Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=IMRN&period=max&api_key=YOUR_API_KEY